ABRAXANE subst sèche 100 mg flac
7680631820012
CH-63182
L01CD01
07.16.1.
Reimbursement limitations:
ABRAXANE
Adénocarcinome du pancréas
En association avec la gemcitabine, dans le traitement de première ligne de …
1 / 3
google
Details
- Product number
- 6318201
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- paclitaxelum 100 mg ut complexus paclitaxeli et albumini humani, albuminum humanum, pro vitro.
Articles (1)
Abraxane 100 mg, Pulver zur Herstellung einer Infusionsdispersion
Pulver
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
100.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 332.10
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/04/2015
Authorization holder
Bristol-Myers Squibb SA
6312 Steinhausen
Authorization information
- Swissmedic authorization number
- 63182
- Drug name
- Abraxane, Pulver zur Herstellung einer Infusionsdispersion
- Galenic form
- PULVID
- ATC Code
- L01CD01
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 26/08/2014
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ABRAXANE subst sèche 100 mg flac
- Description (DE)
- ABRAXANE Trockensub 100 mg Durchstf
- Market launch
- 26/08/2014
- Narcotic (BTM)
- No
Available generics
Paclitaxel-Albumin Spirig HC, Pulver zur Herstellung einer Infusionsdispersion
GTIN:
7680691530012
CHF 210.20
Paclitaxel Fresenius, Konzentrat zur Herstellung einer Infusionslösung
GTIN:
7680630490018
CHF 39.45
Paclitaxel Fresenius, Konzentrat zur Herstellung einer Infusionslösung
GTIN:
7680630490025
CHF 84.35
Paclitaxel Fresenius, Konzentrat zur Herstellung einer Infusionslösung
GTIN:
7680630490032
CHF 220.25